| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.41e-19 | 114 | 141 | 18 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 6.81e-19 | 124 | 141 | 18 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.32e-18 | 137 | 141 | 18 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.92e-15 | 192 | 141 | 18 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 DPP9 USP17L17 USP17L3 CORIN USP17L22 USP17L15 PROC USP17L8 USP17L13 | 6.72e-09 | 654 | 141 | 21 | GO:0008233 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 9.94e-06 | 194 | 141 | 9 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen | 1.18e-05 | 7 | 141 | 3 | GO:0016714 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.39e-05 | 166 | 141 | 8 | GO:0005506 | |
| GeneOntologyMolecularFunction | tryptophan 5-monooxygenase activity | 4.95e-05 | 2 | 141 | 2 | GO:0004510 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 6.88e-05 | 98 | 141 | 6 | GO:0051213 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 9.61e-05 | 65 | 141 | 5 | GO:0016706 | |
| GeneOntologyMolecularFunction | procollagen-proline 3-dioxygenase activity | 1.48e-04 | 3 | 141 | 2 | GO:0019797 | |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 1.48e-04 | 3 | 141 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | peptidyl-proline 3-dioxygenase activity | 2.94e-04 | 4 | 141 | 2 | GO:0031544 | |
| GeneOntologyMolecularFunction | keratin filament binding | 7.29e-04 | 6 | 141 | 2 | GO:1990254 | |
| GeneOntologyMolecularFunction | procollagen-proline dioxygenase activity | 1.35e-03 | 8 | 141 | 2 | GO:0019798 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.35e-03 | 8 | 141 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | phospholipase binding | 1.47e-03 | 32 | 141 | 3 | GO:0043274 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.64e-19 | 125 | 137 | 18 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.63e-18 | 144 | 137 | 18 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 TRIM72 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 LRRK2 USP17L5 RNF213 USP17L10 USP17L19 MED1 USP17L18 USP17L17 ASB6 TRIM17 NT5C2 DZIP3 USP17L3 HERC6 USP17L22 USP17L15 USP17L8 WDR24 USP17L13 | 9.53e-11 | 1009 | 137 | 28 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 TRIM72 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 LRRK2 USP17L5 RNF213 USP17L10 USP17L19 MED1 USP17L18 USP17L17 ASB6 TRIM17 NT5C2 DZIP3 USP17L3 HERC6 USP17L22 USP17L15 USP17L8 WDR24 USP17L13 | 3.96e-10 | 1074 | 137 | 28 | GO:0043687 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 PNPLA2 USP17L4 USP17L12 USP17L1 CYP2E1 USP17L20 USP17L11 LRRK2 RDH10 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CYB5R3 USP17L3 USP17L22 TNPO3 USP17L15 SOAT2 USP17L8 USP17L13 SPINK5 | 2.05e-06 | 1327 | 139 | 25 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 PNPLA2 USP17L4 USP17L12 USP17L1 CYP2E1 USP17L20 USP17L11 LRRK2 RDH10 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CYB5R3 USP17L3 USP17L22 USP17L15 SOAT2 USP17L8 USP17L13 SPINK5 | 4.37e-06 | 1293 | 139 | 24 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 PNPLA2 USP17L4 USP17L12 USP17L1 CYP2E1 USP17L20 USP17L11 LRRK2 RDH10 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CYB5R3 USP17L3 USP17L22 USP17L15 SOAT2 USP17L8 USP17L13 SPINK5 | 4.72e-06 | 1299 | 139 | 24 | GO:0098827 |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 5.46e-26 | 16 | 137 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 5.46e-26 | 16 | 137 | 13 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.37e-21 | 71 | 137 | 17 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.37e-21 | 71 | 137 | 17 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.79e-21 | 72 | 137 | 17 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.79e-21 | 72 | 137 | 17 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.79e-21 | 72 | 137 | 17 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.79e-20 | 66 | 137 | 16 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L4 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 5.07e-20 | 70 | 137 | 16 | PS00972 |
| Domain | ACT_dom | 3.86e-07 | 3 | 137 | 3 | IPR002912 | |
| Domain | ACT | 3.86e-07 | 3 | 137 | 3 | PS51671 | |
| Domain | ACT | 3.86e-07 | 3 | 137 | 3 | PF01842 | |
| Domain | - | 1.54e-06 | 4 | 137 | 3 | 1.10.800.10 | |
| Domain | ArAA_hydroxylase_Fe/CU_BS | 1.54e-06 | 4 | 137 | 3 | IPR018301 | |
| Domain | BH4_AAA_HYDROXYL_2 | 1.54e-06 | 4 | 137 | 3 | PS51410 | |
| Domain | ArAA_hydroxylase | 1.54e-06 | 4 | 137 | 3 | IPR001273 | |
| Domain | Biopterin_H | 1.54e-06 | 4 | 137 | 3 | PF00351 | |
| Domain | Tyrosine_3-monooxygenase-like | 1.54e-06 | 4 | 137 | 3 | IPR019773 | |
| Domain | Aromatic-AA_hydroxylase_C | 1.54e-06 | 4 | 137 | 3 | IPR019774 | |
| Domain | BH4_AAA_HYDROXYL_1 | 1.54e-06 | 4 | 137 | 3 | PS00367 | |
| Domain | VWC | 1.69e-06 | 28 | 137 | 5 | PF00093 | |
| Domain | Unchr_dom_Cys-rich | 1.88e-06 | 13 | 137 | 4 | IPR014853 | |
| Domain | C8 | 1.88e-06 | 13 | 137 | 4 | SM00832 | |
| Domain | TIL_dom | 2.62e-06 | 14 | 137 | 4 | IPR002919 | |
| Domain | VWF_type-D | 4.71e-06 | 16 | 137 | 4 | IPR001846 | |
| Domain | VWFD | 4.71e-06 | 16 | 137 | 4 | PS51233 | |
| Domain | VWD | 4.71e-06 | 16 | 137 | 4 | SM00216 | |
| Domain | VWD | 4.71e-06 | 16 | 137 | 4 | PF00094 | |
| Domain | VWFC_1 | 6.20e-06 | 36 | 137 | 5 | PS01208 | |
| Domain | VWFC_2 | 8.15e-06 | 38 | 137 | 5 | PS50184 | |
| Domain | VWC | 8.15e-06 | 38 | 137 | 5 | SM00214 | |
| Domain | VWF_dom | 1.35e-05 | 42 | 137 | 5 | IPR001007 | |
| Domain | Trp_5_mOase | 5.34e-05 | 2 | 137 | 2 | IPR005963 | |
| Domain | C8 | 8.09e-05 | 12 | 137 | 3 | PF08742 | |
| Domain | TIL | 8.09e-05 | 12 | 137 | 3 | PF01826 | |
| Domain | VWC_out | 3.43e-04 | 19 | 137 | 3 | SM00215 | |
| Domain | FYrich_C | 5.26e-04 | 5 | 137 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.26e-04 | 5 | 137 | 2 | IPR003888 | |
| Domain | FYRC | 5.26e-04 | 5 | 137 | 2 | SM00542 | |
| Domain | FYRN | 5.26e-04 | 5 | 137 | 2 | SM00541 | |
| Domain | FYRN | 5.26e-04 | 5 | 137 | 2 | PF05964 | |
| Domain | FYRC | 5.26e-04 | 5 | 137 | 2 | PF05965 | |
| Domain | FYRC | 5.26e-04 | 5 | 137 | 2 | PS51543 | |
| Domain | FYRN | 5.26e-04 | 5 | 137 | 2 | PS51542 | |
| Domain | WxxW_domain | 7.86e-04 | 6 | 137 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 7.86e-04 | 6 | 137 | 2 | PF13330 | |
| Domain | AT_hook | 9.93e-04 | 27 | 137 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 9.93e-04 | 27 | 137 | 3 | IPR017956 | |
| Domain | IGc2 | 1.76e-03 | 235 | 137 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.76e-03 | 235 | 137 | 7 | IPR003598 | |
| Domain | Ig_I-set | 2.80e-03 | 190 | 137 | 6 | IPR013098 | |
| Domain | I-set | 2.80e-03 | 190 | 137 | 6 | PF07679 | |
| Domain | ZF_CXXC | 2.81e-03 | 11 | 137 | 2 | PS51058 | |
| Domain | Znf_CXXC | 2.81e-03 | 11 | 137 | 2 | IPR002857 | |
| Domain | 2OG-FeII_Oxy_3 | 2.81e-03 | 11 | 137 | 2 | PF13640 | |
| Domain | zf-CXXC | 2.81e-03 | 11 | 137 | 2 | PF02008 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.46e-26 | 45 | 99 | 17 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.02e-15 | 191 | 99 | 18 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.34e-14 | 221 | 99 | 18 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.56e-13 | 262 | 99 | 18 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.42e-12 | 299 | 99 | 18 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 PTPN11 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 6.82e-12 | 318 | 99 | 18 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 PNPLA2 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 JMJD4 USP17L5 USP17L10 MUC5B USP17L19 USP17L18 USP17L17 ASB6 USP17L3 CAPZA3 USP17L22 MUC5AC USP17L15 PROC USP17L8 USP17L13 | 7.65e-06 | 1389 | 99 | 25 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 PNPLA2 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 USP17L24 JMJD4 USP17L5 USP17L10 MUC5B USP17L19 USP17L18 USP17L17 ASB6 USP17L3 CAPZA3 USP17L22 MUC5AC USP17L15 PROC USP17L8 USP17L13 | 2.17e-05 | 1475 | 99 | 25 | M19806 |
| Pathway | REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS | 4.82e-04 | 5 | 99 | 2 | MM14831 | |
| Pathway | REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS | 4.82e-04 | 5 | 99 | 2 | M27119 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM | 4.82e-04 | 5 | 99 | 2 | M47902 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-38 | 21 | 141 | 17 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-38 | 21 | 141 | 17 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-38 | 21 | 141 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-38 | 21 | 141 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-38 | 21 | 141 | 17 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-38 | 21 | 141 | 17 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.06e-37 | 22 | 141 | 17 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.68e-36 | 24 | 141 | 17 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 8.36e-36 | 25 | 141 | 17 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.41e-35 | 26 | 141 | 17 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.79e-35 | 33 | 141 | 18 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.92e-35 | 34 | 141 | 18 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.21e-34 | 35 | 141 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.21e-34 | 35 | 141 | 18 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.42e-34 | 36 | 141 | 18 | 20147298 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.96e-34 | 29 | 141 | 17 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.70e-34 | 37 | 141 | 18 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 6.99e-29 | 50 | 141 | 17 | 31806660 |
| Pubmed | USP17L7 USP17L21 USP17L4 ZNF672 USP17L12 USP17L1 INHA USP17L20 USP17L11 LRRK2 USP17L5 USP17L10 USP17L19 USP17L18 PLA2R1 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.04e-13 | 674 | 141 | 21 | 37196079 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 8.26e-13 | 10 | 141 | 6 | 24207026 | |
| Pubmed | 3.61e-12 | 12 | 141 | 6 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.17e-11 | 14 | 141 | 6 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 1.04e-10 | 19 | 141 | 6 | 28067227 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 HSPG2 PNPLA2 EPPK1 KMT2B ACACA L1CAM RDH10 OBSCN DGKQ FGFRL1 AHDC1 FAM83H PPP1R26 KMT2C TRAF4 MROH1 SH3TC1 PIK3C2B PPP1R15B TNFAIP2 TNPO3 WDR24 | 1.25e-10 | 1105 | 141 | 23 | 35748872 |
| Pubmed | Phenylalanine hydroxylase contributes to serotonin synthesis in mice. | 6.52e-08 | 3 | 141 | 3 | 33993565 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17 | 5.95e-07 | 119 | 141 | 7 | 28625976 |
| Pubmed | 1.01e-06 | 81 | 141 | 6 | 12838346 | ||
| Pubmed | 1.52e-06 | 48 | 141 | 5 | 16421571 | ||
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 7.67e-06 | 10 | 141 | 3 | 29276034 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 KMT2B ACACA USP17L12 CDKL2 OBSCN RNF213 KMT2C ADO RECQL4 USP17L3 FUBP3 RPL12 | 1.02e-05 | 736 | 141 | 13 | 29676528 |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 7513696 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20921119 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.63e-05 | 2 | 141 | 2 | 14988081 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17768266 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 38579707 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15563276 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17621824 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24317696 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.63e-05 | 2 | 141 | 2 | 35776514 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24327612 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20213726 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23836919 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19233335 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 1.63e-05 | 2 | 141 | 2 | 28607090 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23582017 | ||
| Pubmed | Family-based association study of TPH1 and TPH2 polymorphisms in autism. | 1.63e-05 | 2 | 141 | 2 | 16958027 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17986837 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 31030254 | ||
| Pubmed | Synthesis of serotonin by a second tryptophan hydroxylase isoform. | 1.63e-05 | 2 | 141 | 2 | 12511643 | |
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 1.63e-05 | 2 | 141 | 2 | 23527003 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 16540890 | ||
| Pubmed | DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias. | 1.63e-05 | 2 | 141 | 2 | 29174366 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18923670 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 1.63e-05 | 2 | 141 | 2 | 27845589 | |
| Pubmed | Role of Tet1/3 Genes and Chromatin Remodeling Genes in Cerebellar Circuit Formation. | 1.63e-05 | 2 | 141 | 2 | 26711116 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19816759 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 27435107 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 26871672 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20144688 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14563478 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 1.63e-05 | 2 | 141 | 2 | 11587997 | |
| Pubmed | Human placenta expresses both peripheral and neuronal isoform of tryptophan hydroxylase. | 1.63e-05 | 2 | 141 | 2 | 28751217 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 1.63e-05 | 2 | 141 | 2 | 34656442 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 34058148 | ||
| Pubmed | Maternal serotonin is crucial for murine embryonic development. | 1.63e-05 | 2 | 141 | 2 | 17182745 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29314569 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14718370 | ||
| Pubmed | TPH2 and TPH1: association of variants and interactions with heroin addiction. | 1.63e-05 | 2 | 141 | 2 | 18181017 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25005534 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 16581041 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 1.63e-05 | 2 | 141 | 2 | 21653907 | |
| Pubmed | Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes. | 1.63e-05 | 2 | 141 | 2 | 26703470 | |
| Pubmed | Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. | 1.63e-05 | 2 | 141 | 2 | 21073637 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 1.63e-05 | 2 | 141 | 2 | 36427316 | |
| Pubmed | Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis. | 1.63e-05 | 2 | 141 | 2 | 26294212 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14597720 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19181488 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 1.63e-05 | 2 | 141 | 2 | 23272068 | |
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 1.63e-05 | 2 | 141 | 2 | 27729120 | |
| Pubmed | The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. | 1.63e-05 | 2 | 141 | 2 | 19436308 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 36111525 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29697747 | ||
| Pubmed | Isoform-Specific Substrate Inhibition Mechanism of Human Tryptophan Hydroxylase. | 1.63e-05 | 2 | 141 | 2 | 29035515 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19032713 | ||
| Pubmed | LEPREL1, a novel ER and Golgi resident member of the Leprecan family. | 1.63e-05 | 2 | 141 | 2 | 15063763 | |
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 1.63e-05 | 2 | 141 | 2 | 32348677 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 1.63e-05 | 2 | 141 | 2 | 24332705 | |
| Interaction | FLT3 interactions | USP17L21 EPPK1 USP17L12 USP17L20 USP17L11 RNF213 USP17L19 USP17L18 PTPN11 USP17L17 TNPO3 | 9.32e-06 | 318 | 134 | 11 | int:FLT3 |
| Interaction | TPH2 interactions | 9.87e-06 | 7 | 134 | 3 | int:TPH2 | |
| Interaction | TOP3B interactions | VWA5B2 HSPG2 PNPLA2 EPPK1 KMT2B ACACA L1CAM RDH10 OBSCN DGKQ FGFRL1 AHDC1 ZFP36 FAM83H PPP1R26 KMT2C TRAF4 MROH1 SH3TC1 PIK3C2B PPP1R15B TNFAIP2 FUBP3 TNPO3 WDR24 | 1.18e-05 | 1470 | 134 | 25 | int:TOP3B |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 SH3TC1 USP17L17 USP17L22 USP17L15 USP17L13 | 3.59e-21 | 79 | 141 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 DGKQ FGFRL1 USP17L10 USP17L19 USP17L18 SH3TC1 USP17L17 USP17L22 USP17L15 USP17L13 | 1.46e-17 | 222 | 141 | 16 | chr4p16 |
| Cytoband | 8p23.1 | 1.19e-04 | 154 | 141 | 5 | 8p23.1 | |
| Cytoband | 8q24.3 | 4.24e-04 | 113 | 141 | 4 | 8q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 8.12e-04 | 234 | 141 | 5 | chr8p23 | |
| GeneFamily | Zinc fingers CXXC-type | 1.65e-05 | 12 | 78 | 3 | 136 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.87e-05 | 161 | 78 | 6 | 593 | |
| GeneFamily | Ring finger proteins | 1.20e-03 | 275 | 78 | 6 | 58 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.51e-22 | 86 | 140 | 17 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.02e-20 | 112 | 140 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.56e-17 | 160 | 140 | 17 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 DGKQ USP17L10 USP17L19 FAM83H USP17L18 PLA2R1 TRAF4 PTPN11 USP17L17 RECQL4 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 6.35e-13 | 647 | 140 | 23 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 PNPLA2 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 RDH10 USP17L5 DGKQ USP17L10 USP17L19 ZFP36 FAM83H USP17L18 PLA2R1 TRAF4 PTPN11 USP17L17 TRIM17 RECQL4 PTRH1 USP17L3 USP17L22 USP17L15 USP17L8 TECPR1 USP17L13 | 1.13e-11 | 1226 | 140 | 29 | MM979 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 P3H3 USP17L20 USP17L11 USP17L5 FGFRL1 USP17L10 USP17L19 SVEP1 USP17L18 PTPN11 USP17L17 USP17L3 BMPER HERC6 USP17L22 KCNAB3 USP17L15 USP17L8 USP17L13 | 2.18e-08 | 1198 | 140 | 24 | MM1062 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 MAT2B USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 LRP10 USP17L17 TRIM17 DZIP3 USP17L3 MLLT3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.98e-08 | 1072 | 140 | 22 | MM1031 |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-07 | 159 | 133 | 7 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.36e-07 | 164 | 133 | 7 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 196 | 133 | 7 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.39e-06 | 200 | 133 | 7 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-06 | 160 | 133 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-06 | 160 | 133 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 166 | 133 | 6 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 166 | 133 | 6 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 168 | 133 | 6 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-05 | 169 | 133 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 175 | 133 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 180 | 133 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.70e-05 | 180 | 133 | 6 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 180 | 133 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.81e-05 | 182 | 133 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-05 | 182 | 133 | 6 | 0e589bf97d51b4b2f723f8c45853ad81b7ce8778 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-05 | 183 | 133 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-05 | 186 | 133 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-05 | 188 | 133 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 190 | 133 | 6 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 190 | 133 | 6 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 190 | 133 | 6 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 190 | 133 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 191 | 133 | 6 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 191 | 133 | 6 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 191 | 133 | 6 | c715bbdbbf1482aad45a50a16d5232fd35a9a0bb | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 191 | 133 | 6 | 243d83cbfcc4996ad087ec6386e559e0b8662004 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 191 | 133 | 6 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 192 | 133 | 6 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.52e-05 | 193 | 133 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.59e-05 | 194 | 133 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 194 | 133 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 194 | 133 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 195 | 133 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 197 | 133 | 6 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 197 | 133 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC2|ICU-SEP / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | 09d5c3a3d2b42b15c769dc2bc14b6c0d5cc38f91 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 62 | 133 | 4 | 91c49ae176d2a418a58398e9d5e55c77187cc2fb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 62 | 133 | 4 | 3275775572a65460b6248ee72b4c85e4d4dee424 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 5.92e-05 | 138 | 133 | 5 | b2ab273f3e62f169b3b9cb82342e6617af99f582 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 74 | 133 | 4 | 0288a3f4eafbc359d01cde4ba58f946dd07c77cb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 74 | 133 | 4 | 57884ade66fe39398351685189df5efd7aea0aab | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 74 | 133 | 4 | 13093139a75bfe11f6b032c9fb402efcc703551c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Vwf)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 74 | 133 | 4 | 7f7de9e8142d2435391ee965cee5628e412f0705 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.49e-05 | 145 | 133 | 5 | f6ba6cf0c8d0ee87a7904485b27eb9261fcb6edd | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.73e-05 | 146 | 133 | 5 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.51e-05 | 149 | 133 | 5 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 155 | 133 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.16e-04 | 159 | 133 | 5 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 160 | 133 | 5 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-04 | 163 | 133 | 5 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-04 | 165 | 133 | 5 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 1.41e-04 | 166 | 133 | 5 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 166 | 133 | 5 | 430d604f5bef9fae20dc81492e6695616f6701a3 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-04 | 166 | 133 | 5 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-04 | 166 | 133 | 5 | eb9c81fa7573de7aff6670e7dad313f02129809f | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.45e-04 | 167 | 133 | 5 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-04 | 167 | 133 | 5 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 167 | 133 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 167 | 133 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 167 | 133 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 168 | 133 | 5 | 38ba7737ae0afffcbd3aa499403e83c24a922127 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-04 | 168 | 133 | 5 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 170 | 133 | 5 | b62f7184e78e9672ea88e361654f604f9df2dc5f | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 170 | 133 | 5 | 00fe77bca9c28762212c498f9c49e14cb1492cca | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 170 | 133 | 5 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.58e-04 | 170 | 133 | 5 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 170 | 133 | 5 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 171 | 133 | 5 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 172 | 133 | 5 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 172 | 133 | 5 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 173 | 133 | 5 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 173 | 133 | 5 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 173 | 133 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 173 | 133 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 173 | 133 | 5 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 1.76e-04 | 174 | 133 | 5 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.81e-04 | 175 | 133 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.81e-04 | 175 | 133 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-04 | 176 | 133 | 5 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.86e-04 | 176 | 133 | 5 | 195393b38f1335f2cb96125616d75c164a6026c2 | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.86e-04 | 176 | 133 | 5 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-04 | 177 | 133 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.91e-04 | 177 | 133 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 179 | 133 | 5 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | droplet-Limb_Muscle-nan-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 180 | 133 | 5 | d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 180 | 133 | 5 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.06e-04 | 180 | 133 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 180 | 133 | 5 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 181 | 133 | 5 | 3fd16229a63de0971db5d48860c01173d7db518f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 181 | 133 | 5 | 2392af8c7f040c23a7d416c2e37419954970c8f4 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 182 | 133 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.17e-04 | 182 | 133 | 5 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 182 | 133 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 183 | 133 | 5 | 4de2082dca2569d3aac3c9b466f27971c82d302b | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.22e-04 | 183 | 133 | 5 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 183 | 133 | 5 | a046b569bc10083d471b420eb2c6fee93437602d | |
| Drug | 4-vinylcatechol | 1.60e-06 | 5 | 125 | 3 | CID000151398 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 DMRT3 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.76e-33 | 46 | 137 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 KMT2B USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 KMT2C USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.88e-31 | 69 | 137 | 20 | DOID:1682 (implicated_via_orthology) |
| Disease | Autism Spectrum Disorders | 4.88e-05 | 85 | 137 | 5 | C1510586 | |
| Disease | COVID-19 symptoms measurement | 5.75e-04 | 35 | 137 | 3 | EFO_0600019 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 7.33e-04 | 38 | 137 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | BMI-adjusted waist circumference, forced expiratory volume | 7.54e-04 | 9 | 137 | 2 | EFO_0004314, EFO_0007789 | |
| Disease | hypertrophic cardiomyopathy | 9.06e-04 | 92 | 137 | 4 | EFO_0000538 | |
| Disease | pulmonary fibrosis | 1.15e-03 | 11 | 137 | 2 | EFO_0009448 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.37e-03 | 12 | 137 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | depressive disorder (biomarker_via_orthology) | 1.83e-03 | 52 | 137 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | Hamman-Rich syndrome | 1.88e-03 | 14 | 137 | 2 | C0085786 | |
| Disease | Carcinoma, Granular Cell | 2.13e-03 | 116 | 137 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.13e-03 | 116 | 137 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.13e-03 | 116 | 137 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.13e-03 | 116 | 137 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.13e-03 | 116 | 137 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.13e-03 | 116 | 137 | 4 | C0001418 | |
| Disease | idiopathic pulmonary fibrosis | 2.39e-03 | 57 | 137 | 3 | EFO_0000768 | |
| Disease | cathepsin L1 measurement | 2.46e-03 | 16 | 137 | 2 | EFO_0010619 | |
| Disease | daytime rest measurement | 2.61e-03 | 295 | 137 | 6 | EFO_0007828 | |
| Disease | Sjogren syndrome | 2.76e-03 | 60 | 137 | 3 | EFO_0000699 | |
| Disease | alpha-L-iduronidase measurement | 2.78e-03 | 17 | 137 | 2 | EFO_0020139 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.89e-03 | 61 | 137 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Usual Interstitial Pneumonia | 3.47e-03 | 19 | 137 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 3.47e-03 | 19 | 137 | 2 | C4721508 | |
| Disease | bipolar disorder (is_marker_for) | 3.47e-03 | 19 | 137 | 2 | DOID:3312 (is_marker_for) | |
| Disease | limited scleroderma | 3.47e-03 | 19 | 137 | 2 | EFO_1001017 | |
| Disease | interstitial lung disease | 3.78e-03 | 67 | 137 | 3 | EFO_0004244 | |
| Disease | glaucoma (is_marker_for) | 3.85e-03 | 20 | 137 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.85e-03 | 20 | 137 | 2 | C4721952 | |
| Disease | age-related macular degeneration, COVID-19 | 4.10e-03 | 69 | 137 | 3 | EFO_0001365, MONDO_0100096 | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.24e-03 | 21 | 137 | 2 | C1800706 | |
| Disease | stomach cancer (is_implicated_in) | 4.62e-03 | 72 | 137 | 3 | DOID:10534 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PAHPEAVQAHVLGCF | 166 | Q86Y79 | |
| SQGACAEHLPHRPAV | 31 | A8MUN3 | |
| RLPIEDHKRFHPDCG | 111 | Q13075 | |
| VPLCIDGNPVLLSHH | 61 | Q96KX2 | |
| LFPLAPQEITHCHDE | 536 | P49902 | |
| GPCILTPHRDNLHQI | 181 | Q96SZ5 | |
| LHLEGHPPVNHLRCE | 106 | P42568 | |
| ASPQPCGLASHEEHR | 276 | Q9C073 | |
| PLICHTGHEQAGREP | 61 | Q96L96 | |
| CGLIARSDVHHPPVL | 256 | Q8NCL9 | |
| VRALECHPDKHPENP | 36 | Q9UKB3 | |
| HHIPEDPGHLELCRL | 336 | P52824 | |
| DFEDSAHVPCPRGHV | 491 | Q13085 | |
| LLAHGADPSECPAHE | 246 | Q9NWX5 | |
| QAHLSCRDLPLGQPH | 1441 | Q5TGY3 | |
| IPEELCGHHLPQQSL | 141 | Q8IYB7 | |
| ELRNHQPREPHCDLE | 1016 | Q00975 | |
| QERRVHEETVPLHCP | 5706 | Q9HC84 | |
| HEETVPLHCPNGSAI | 5711 | Q9HC84 | |
| PNLDHVGHPTERCFV | 286 | P00387 | |
| EHEENPCQLREPCLH | 4141 | P98160 | |
| KEHHQSLDPNCPRDL | 251 | P05181 | |
| HPVHADNCVLDPDTG | 581 | Q8IVL6 | |
| SQERPCHLDLHQREP | 1066 | Q9UPP5 | |
| CHLDLHQREPNSDIP | 1071 | Q9UPP5 | |
| PELHEECEGNHPSAR | 516 | Q7Z628 | |
| PGEDHILEHLPARLN | 291 | Q96AD5 | |
| SHIFLLCPEHIDQAP | 321 | Q8NEZ4 | |
| AHPDRIIFPNHACED | 16 | Q7Z4F1 | |
| QPHVIVHCAAERRPD | 86 | Q9NZL9 | |
| VAHGDLLELDPPANH | 91 | P78508 | |
| NELICPRENDPVHGA | 926 | Q9NQ38 | |
| RMNHHPLEEDCPPVL | 506 | Q9NYF5 | |
| LCEEHGSPAAPQHLL | 446 | Q8N441 | |
| PVTLRLPRCGHHEVD | 161 | Q7Z3T1 | |
| QPPHLHFEEQGCEGD | 286 | A6NFC9 | |
| HLRVDPPETGVSHLC | 246 | Q8NA70 | |
| PPDRCQHAAHIISEL | 306 | Q96I24 | |
| LEDDLLRALPCHSPH | 461 | Q8IVU3 | |
| LHPGAQRLHIGCDEV | 136 | Q8WVB3 | |
| HRPVIELPHCENSEI | 1676 | Q5S007 | |
| PCLLIQIPEEYEGHH | 16 | P32004 | |
| GVPGHPEALHLECQS | 916 | P32004 | |
| HPFCLEEAERPLPQH | 1226 | Q9UMN6 | |
| DHPHPAVRCVQELLV | 471 | Q96MN2 | |
| CRAESHPEVNIEHLG | 4676 | P98088 | |
| DHTRVVLHDGDPNEP | 286 | Q06124 | |
| SHPIHADNCLLDPEA | 576 | Q8IVL5 | |
| LHGVRHPQDPCSSDA | 191 | Q6WN34 | |
| LDERGHPNPQTGHCR | 101 | Q9Y6Z4 | |
| DGLVHPDPAILFHTC | 1021 | Q8NDA8 | |
| EAPQSEAPRVEECHH | 811 | P28290 | |
| EAPRVEECHHGRTPT | 816 | P28290 | |
| TCRLHVLLPEEFPGH | 1186 | Q86Y13 | |
| VECHPHLALERGLED | 146 | Q14451 | |
| PDICHELLGHVPLFS | 281 | P00439 | |
| HLIHAPPEVAECDLV | 1456 | O00750 | |
| QHLERCPHVPIAVAG | 5721 | Q5VST9 | |
| VDPHHILIEDPDGSC | 6056 | Q5VST9 | |
| HVDGDQCLVLPLEHP | 86 | P04070 | |
| CPREEHAVHAVPVDL | 51 | O43900 | |
| HASRLHPQEPCLKDG | 131 | Q5W5W9 | |
| DPDKRPFCAELLHHD | 271 | Q92772 | |
| ALPCRAPHFHIDLDG | 446 | Q8N8U9 | |
| VLHGCPLPRAELDQH | 1411 | Q8WZ74 | |
| PKCHAEQNHLLIEGP | 221 | Q9NQL9 | |
| PNERHSIRCPESGEH | 836 | Q86TI2 | |
| LCDTHLHPRNQLAGP | 281 | Q9H9V9 | |
| NTGEHIPPCRALCEH | 521 | Q9Y5Q5 | |
| SRGPLAPNHVHEVCL | 31 | Q8N112 | |
| GQRLEDVHHRPECRP | 31 | Q7Z6J4 | |
| RPPEEPAAHANCHRV | 251 | P05111 | |
| LCPEELEHVSRHLRP | 56 | Q6ZRV2 | |
| CRVLVHRPHGPELDA | 401 | Q9BVI4 | |
| AHHGENPVSCPELVQ | 126 | Q15648 | |
| QHRGEHAPELVLEPD | 456 | Q8WUT4 | |
| HQEINHFLCDVPPVL | 176 | Q8NGQ4 | |
| FNLIPPVCEQAEHHL | 246 | O43448 | |
| DALCTPHSHDPRDLQ | 16 | Q8N9W8 | |
| HELGHFNIPTLCDPA | 381 | Q8N3R3 | |
| AVEHAENPCHKEEPR | 981 | Q96DN5 | |
| EDEHPQCLNSQPHAR | 161 | Q8NHL6 | |
| PAHCHLFLQPQGEDL | 811 | O94761 | |
| PRCRGCLAHGEEHPE | 956 | Q6ZWJ8 | |
| HIPLGELAAHCVRPC | 1506 | Q6ZWJ8 | |
| VDPVHGVHLPQAAAC | 1366 | P58107 | |
| EGRSEPHHLCDPQKT | 771 | Q7Z443 | |
| PHHLCDPQKTVFERG | 776 | Q7Z443 | |
| GRPIHCQVPGIDHFL | 1401 | Q9UKZ4 | |
| LIQEGPFFVLCPDHH | 206 | Q8TE82 | |
| EGCHDARPAAKPTVH | 76 | Q5T8A7 | |
| REDHCHPQPLSAELI | 261 | Q5SWA1 | |
| CPLPENITHILVHGD | 3181 | Q4LDE5 | |
| GHHLLECPDELIERT | 151 | Q8IZV5 | |
| ICHVPPETRQSEHPE | 1231 | Q13018 | |
| VHVAVEHQLPPASRC | 216 | O75908 | |
| RCGHGEEQKLELNPH | 676 | Q8NFU7 | |
| GHDPEPGRLLCQAQH | 111 | Q8N9L9 | |
| VTLPCHHQLGLPEKD | 31 | Q9H6B4 | |
| QAHLSEDCPDVPALH | 326 | Q15846 | |
| IDCHAPIGGIDHKPR | 4526 | Q63HN8 | |
| CHELLGHVPLLAEPS | 271 | P17752 | |
| DHPCLQAPELDEHLV | 411 | A6NCW0 | |
| DVPPQRLDGHCHSEL | 346 | Q03169 | |
| HGQNECDIPTQLPVH | 2001 | Q8N2C7 | |
| DHPCLQVPELDEHLV | 411 | A6NCW7 | |
| SDHHEPICKPGLELN | 466 | Q76I76 | |
| CNVDGRHPHDIIDDI | 141 | P30050 | |
| PGNEHKIVPEALLCH | 221 | Q9UNN4 | |
| SPDLEAHEHPLPCDQ | 746 | Q7Z6L1 | |
| HQRIHTGEKPFACPE | 301 | Q499Z4 | |
| QHHDDILCAAFLPPQ | 281 | Q8IV35 | |
| DHPCLQAPELDEHLV | 411 | D6R9N7 | |
| RCHFIHNPSEDLAAP | 161 | P26651 | |
| DHPCLQAPELDEHLV | 411 | A8MUK1 | |
| DHPCLQAPELDEHLV | 411 | D6R901 | |
| DHPCLQAPELDEHLV | 411 | C9JLJ4 | |
| DHPCLQAPELDEHLV | 411 | D6RCP7 | |
| EALHEQGVLCRDLHP | 401 | Q9Y6S9 | |
| NDDRDPPQHHSCLPD | 1056 | Q68DE3 | |
| PHSHGEEAVAQDRIP | 1581 | O95359 | |
| LSRRDLPAHLQHDCP | 121 | Q9BUZ4 | |
| VPQGHCEEHLDPLSI | 81 | Q6ZMU5 | |
| DHPCLQAPELDEHLV | 411 | Q7RTZ2 | |
| PGPAHTARLEDAHDL | 186 | O43151 | |
| TCHELLGHVPLLADP | 316 | Q8IWU9 | |
| APVNSIHPECRFHLE | 16 | P41587 | |
| PGLQKQDLCQEHHEP | 91 | Q9Y577 | |
| LARHCQLEPDHEGVP | 376 | Q9Y5L0 | |
| DHPCLQAPELDEHLV | 411 | C9JPN9 | |
| HQRLHTGERPFQCPE | 611 | Q8N393 | |
| ELSDLPGECRAHGHL | 786 | Q96AY4 | |
| HCDRALEILLHPSEP | 261 | Q8N398 | |
| DHPCLQAPELDEHLV | 411 | Q0WX57 | |
| DHPCLQVPELDEHLV | 411 | P0C7H9 | |
| DHPCLQVPELDEHLV | 411 | P0C7I0 | |
| VFHEDCHIPPVEAER | 711 | Q13342 | |
| EHAHPEDPECVLPQE | 556 | Q96S15 | |
| TEDHSHLQEPALCGP | 246 | O43915 | |
| DHPCLQAPELDEHLV | 411 | D6RA61 | |
| DPHCHLQLEAPQLDV | 491 | P0DP72 | |
| DHPCLQAPELDEHLV | 411 | C9J2P7 | |
| DHPCLQAPELDEHLV | 411 | D6RBQ6 | |
| EDIHRPVLGEPEIHQ | 336 | O95125 | |
| HQRIHSGEEPHKCPE | 341 | Q6P9G9 | |
| DHPCLQAPELDEHLV | 411 | D6RJB6 | |
| DHPCLQAPELDEHLV | 411 | C9JJH3 | |
| VVENQLPHCLPAHDS | 461 | Q5H9K5 | |
| DHPCLQAPELDEHLV | 411 | C9JVI0 | |
| CLPIPLDAGSHVADH | 2436 | Q9P2D8 |